| CEO Name | Michael M. Morrissey |
| Nationality | United States |
| Net Worth Estimation | $60 million |
Michael M. Morrissey's estimated net worth of around $60 million primarily results from his long-term tenure as CEO of Exelixis, Inc., significant stock ownership, equity awards, and substantial executive compensation packages. His financial growth is closely tied to Exelixis' market performance, drug pipeline success, and consequent share value appreciation.
Michael M. Morrissey's estimated net worth of $60,000,000 is within the $10,000,000 to $90,000,000 CEO net worth range for the healthcare sector. His net worth is approximately 62.5% of the maximum estimated CEO net worth in this category.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Michael M. Morrissey Performance in Exelixis, Inc.
Michael M. Morrissey, CEO of Exelixis, Inc., demonstrates strategic leadership by driving innovation and expanding the company's oncology drug portfolio. His decision-making focuses on robust R&D investment and collaborative partnerships, significantly enhancing Exelixis's market position. Under Morrissey's tenure, the company has achieved consistent revenue growth and strengthened its pipeline, solidifying its role in cancer treatment advancements.
Latest News
Exelixis Reports Strong Q3 Earnings with CEO Stressing Oncology Growth
Exelixis, Inc. reported better-than-expected Q3 2025 earnings and revenue, with net income of $193.6 million. CEO Michael Morrissey emphasized strategic growth through expanding the company's oncology pipeline and innovation at a recent Wells Fargo conference.
Source: http://www.timesunion.com/business/article/exelixis-q3-earnings-snapshot-21138997.php